Truist Financial Lowers Community Health Systems (NYSE:CYH) Price Target to $3.50

Key Points

• Truist Financial cut its price target on Community Health Systems to $3.50 (from $4.00) and kept a "hold" rating, implying roughly a 14.64% upside from the prior close.
• The consensus remains a Hold with an average price target of $3.45, and analysts are mixed (1 Strong Buy, 1 Buy, 4 Hold, 2 Sell).
• CYH shares traded down about 3.1% to $3.05, with a market cap near $430M, a 52‑week range of $2.26–$4.47, and roughly 85% institutional ownership.

Community Health Systems (NYSE:CYH - Get Free Report) had its price objective lowered by research analysts at Truist Financial from $4.00 to $3.50 in a report issued on Monday,Benzinga reports. The brokerage presently has a "hold" rating on the stock. Truist Financial's price target points to a potential upside of 14.64% from the company's previous close.

A number of other research firms also recently weighed in on CYH. UBS Group increased their price objective on Community Health Systems from $3.60 to $3.70 and gave the company a "neutral" rating in a report on Friday, February 20th. Zacks Research upgraded Community Health Systems from a "hold" rating to a "strong-buy" rating in a report on Monday, February 23rd. Weiss Ratings downgraded Community Health Systems from a "hold (c-)" rating to a "sell (d+)" rating in a report on Thursday, March 19th. Finally, Wells Fargo & Company decreased their price target on Community Health Systems from $3.00 to $2.00 and set an "underweight" rating for the company in a report on Wednesday, January 7th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have given a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $3.45.

Community Health Systems Trading Down 3.1%

NYSE CYH traded down $0.10 on Monday, hitting $3.05. 638,106 shares of the company's stock were exchanged, compared to its average volume of 1,578,531. The stock has a 50-day moving average of $3.21 and a 200-day moving average of $3.28. Community Health Systems has a 52 week low of $2.26 and a 52 week high of $4.47. The stock has a market cap of $430.26 million, a price-to-earnings ratio of 0.81 and a beta of 1.97.

Hedge Funds Weigh In On Community Health Systems

Institutional investors and hedge funds have recently made changes to their positions in the stock. Royal Bank of Canada lifted its position in Community Health Systems by 601.9% in the 4th quarter. Royal Bank of Canada now owns 9,286 shares of the company's stock valued at $29,000 after acquiring an additional 7,963 shares in the last quarter. Wealth Enhancement Advisory Services LLC bought a new position in Community Health Systems in the 3rd quarter valued at about $32,000. Lazard Asset Management LLC bought a new position in Community Health Systems in the 4th quarter valued at about $34,000. Wealthcare Advisory Partners LLC bought a new position in Community Health Systems in the 4th quarter valued at about $35,000. Finally, Valeo Financial Advisors LLC bought a new position in Community Health Systems in the 4th quarter valued at about $39,000. Institutional investors own 84.99% of the company's stock.

Community Health Systems Company Profile

Community Health Systems, Inc NYSE: CYH is one of the largest publicly traded hospital operators in the United States. Headquartered in Franklin, Tennessee, the company owns, leases and manages general acute care hospitals and outpatient facilities, primarily in non-urban and mid-market communities. CHS is focused on delivering locally accessible healthcare services through its network of affiliated hospitals, clinics and post-acute providers.

The company's core offerings include inpatient medical and surgical care, emergency services, critical care, diagnostic imaging and laboratory testing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.